Correlation Between Medicofarma Biotech and Immobile

Can any of the company-specific risk be diversified away by investing in both Medicofarma Biotech and Immobile at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medicofarma Biotech and Immobile into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Medicofarma Biotech SA and Immobile, you can compare the effects of market volatilities on Medicofarma Biotech and Immobile and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medicofarma Biotech with a short position of Immobile. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medicofarma Biotech and Immobile.

Diversification Opportunities for Medicofarma Biotech and Immobile

0.23

Correlation Coefficient

Medicofarma Biotech  Immobile

Modest diversification

The 3 months correlation between Medicofarma and Immobile is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Medicofarma Biotech SA and Immobile in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immobile and Medicofarma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medicofarma Biotech SA are associated (or correlated) with Immobile. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immobile has no effect on the direction of Medicofarma Biotech i.e., Medicofarma Biotech and Immobile go up and down completely randomly.

Pair Corralation between Medicofarma Biotech and Immobile

Assuming the 90 days trading horizon Medicofarma Biotech SA is expected to under-perform the Immobile. In addition to that, Medicofarma Biotech is 1.71 times more volatile than Immobile. It trades about -0.13 of its total potential returns per unit of risk. Immobile is currently generating about 0.02 per unit of volatility. If you would invest  195.00  in Immobile on September 2, 2024 and sell it today you would earn a total of  2.00  from holding Immobile or generate 1.03% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.44%
Values	Daily Returns

Medicofarma Biotech SA  vs.  Immobile

Medicofarma Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medicofarma Biotech SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Immobile

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Immobile are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Immobile is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Medicofarma Biotech and Immobile

The main advantage of trading using opposite Medicofarma Biotech and Immobile positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medicofarma Biotech position performs unexpectedly, Immobile can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immobile will offset losses from the drop in Immobile's long position.

The idea behind Medicofarma Biotech SA and Immobile pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.